{"disease":{"id":"evaluate-the-safety-and-efficacy-of-denosumab-in-pediatric-subjects-with","name":"evaluate the safety and efficacy of denosumab in pediatric subjects with"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03164928","title":"Safety and Efficiency of Denosumab in Pediatric Subjects With Glucocorticoid-induced Osteoporosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Amgen","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}